COLL vs ROP
Collegium Pharmaceutical Inc (COLL) versus Roper Technologies, Inc. (ROP) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Roper Technologies, Inc. (ROP) is a software - application company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported ROP revenue for 2024-12-31 was $1.88B. Net income was $462.3M. Revenue was up 6.4% from 2024-09-30 to 2024-12-31. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
Not investment advice. Open the COLL and ROP stock pages for the full models.
Not investment advice.